Summary
- Current Price
- As of today, APUS price is $1.23, up +11.82% on
- Current Price All-Time High
- APUS price is currently -69.49% below its historical high of $4.03 set on
- Market Cap
- APUS current market cap is $15M, with unknown 1-year change
- PE Ratio
- APUS PE ratio is unknown
- Revenue
- APUS current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- As of today, the next earnings release for APUS has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Apimeds Pharmaceuticals US, Inc |
| Ticker | NYSEAmerican: APUS |
| Exchange | NYSE American |
| Sector | Healthcare |
| Industry | Specialty & Generic Drug Manufacturers |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | apimedsus.com |
| Employees | 2 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $1.23 | ||
| Price, 1D Change | +11.82% | |
| $15M | ||
| - | ||
| - | ||
| 1.52 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$0.12 | ||
| EPS, 1Y Change | -93.80% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | N/A | |
| Last Ann. Earnings | N/A | |
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$0.12 | ||
| EPS Estimate | N/A | - |
| EPS Est. Change | N/A | - |
| $0.00 | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| $1.23 | ||
| Price Target | - | - |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
Revenue
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| - | ||
| - | ||
| 0.00% | ||
| - | ||
| -93.80% | ||
| -33.48% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| $1.23 | ||
| $1.91 | ||
| SMA 200 vs Price | +55.54% | |
| $1.79 | ||
| SMA 50 vs Price | +45.59% | |
| 1.52 | ||
| $0.28 | ||
| 37.76 | ||
| 173.93% | ||
| 125.05% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$0.12 | ||
| $0.00 | ||
| - | ||
| -$1.28M | ||
| - | ||
| -$1.39M | ||
| - | ||
| -$1.27M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| -0.44 | ||
| 0.01 | ||
| 0.01 | ||
| -10.81 | ||
| - | ||
| -875.73 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 1.90 | ||
| -1.75 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| -$1.36M | ||
| $3,500.00 | ||
| $13.10K | ||
| $13.10K | ||
| $1.37M | ||
| $1.02M | ||
| $596.80K | ||
| $250.00K | ||
| $0.00 |
Expenses
| Metric | Date | Value |
|---|---|---|
| $1.28M | ||
| $1.28M | ||
| $0.00 | ||
| $1.28M | ||
| - | ||
| $117.70K | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$733.50K | ||
| $0.00 | ||
| $326.50K | ||
| $0.00 | ||
| -$733.50K |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| No data | N/A | N/A |
Analyst sentiment
Institutional ownership
Screeners with APUS
FAQ
What is the ticker symbol for Apimeds Pharmaceuticals US, Inc?
The ticker symbol for Apimeds Pharmaceuticals US, Inc is NYSEAmerican:APUS
Does Apimeds Pharmaceuticals US, Inc pay dividends?
No, Apimeds Pharmaceuticals US, Inc does not pay dividends
What sector is Apimeds Pharmaceuticals US, Inc in?
Apimeds Pharmaceuticals US, Inc is in the Healthcare sector
What industry is Apimeds Pharmaceuticals US, Inc in?
Apimeds Pharmaceuticals US, Inc is in the Specialty & Generic Drug Manufacturers industry
What country is Apimeds Pharmaceuticals US, Inc based in?
Apimeds Pharmaceuticals US, Inc is headquartered in United States
When did Apimeds Pharmaceuticals US, Inc go public?
Apimeds Pharmaceuticals US, Inc initial public offering (IPO) was on May 9, 2025
Is Apimeds Pharmaceuticals US, Inc in the S&P 500?
No, Apimeds Pharmaceuticals US, Inc is not included in the S&P 500 index
Is Apimeds Pharmaceuticals US, Inc in the NASDAQ 100?
No, Apimeds Pharmaceuticals US, Inc is not included in the NASDAQ 100 index
Is Apimeds Pharmaceuticals US, Inc in the Dow Jones?
No, Apimeds Pharmaceuticals US, Inc is not included in the Dow Jones index
When does Apimeds Pharmaceuticals US, Inc report earnings?
The date for Apimeds Pharmaceuticals US, Inc's next earnings report has not been announced yet
Data Sources & References
- APUS Official Website www.apimedsus.com
- APUS Profile on Yahoo Finance finance.yahoo.com/quote/APUS
- APUS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/apus